DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-6.23%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$4.75B
AUM Growth
+$4.75B
(-7.1%)
Cap. Flow
-$1.71M
Cap. Flow
% of AUM
-0.04%
Top 10 Holdings %
Top 10 Hldgs %
40.09%
Holding
155
New
21
Increased
16
Reduced
21
Closed
27
Top Buys
| 1 |
AdaptHealth
AHCO
|
$51.9M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$46.6M |
| 3 |
Xilio Therapeutics
XLO
|
$33.7M |
| 4 |
Viatris
VTRS
|
$26.4M |
| 5 |
Esperion Therapeutics
ESPR
|
$25M |
Top Sells
| 1 |
Cytokinetics
CYTK
|
$33.2M |
| 2 |
Molina Healthcare
MOH
|
$30.8M |
| 3 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
$28.5M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$25M |
| 5 |
Pacira BioSciences
PCRX
|
$22.3M |
Sector Composition
| 1 | Healthcare | 63.21% |
| 2 | Financials | 1.41% |
| 3 | Consumer Discretionary | 0.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
CVRx
CVRX
$204M
| – | – |
-413,747
| Closed | -$6.84M |
|
127
Black Diamond Therapeutics
BDTX
$164M
| – | – |
-760,128
| Closed | -$6.43M |
|
128
BridgeBio Pharma
BBIO
$9.91B
| – | – |
0
| – | – |
|
|
JBIO
129
Jade Biosciences, Inc. Common Stock
JBIO
$245M
| – | – |
-20,408
| Closed | -$15M |
|
130
Aveanna Healthcare
AVAH
$1.74B
| – | – |
-1,013,007
| Closed | -$8.12M |
|
131
Aurinia Pharmaceuticals
AUPH
$1.58B
| – | – |
0
| – | – |
|
|
EUCRU
132
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
| – | – |
-1,000,000
| Closed | -$9.95M |
|